COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System

被引:92
作者
Abboud, Hilal [1 ]
Abboud, Fatima Zahra [4 ]
Kharbouch, Hanane [2 ]
Arkha, Yasser [1 ]
El Abbadi, Najia [3 ]
El Ouahabi, Abdessamad [1 ]
机构
[1] Mohamed V Univ Hosp, Dept Neurosurg, Rabat, Morocco
[2] Mohamed V Univ Hosp, Dept Cardiovasc Dis, Rabat, Morocco
[3] Abulcasis Univ Hosp, Dept Neurosurg, Rabat, Morocco
[4] Hassan II Univ Hosp, Dept Radiotherapy & Neurooncol, Fes, Morocco
关键词
COVID-19; Long-term consequence; Nervous system; Pathophysiology; SARS-Cov-2; RESPIRATORY SYNDROME CORONAVIRUS;
D O I
10.1016/j.wneu.2020.05.193
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since December 2019, when the virus was identified in humans, the literature on COVID-19 has grown exponentially and extrarespiratory symptoms including neurologic symptoms are increasingly highlighted. METHODS: Given the high and increasing number of publications reporting neurologic involvements of SARS-Cov-2, we thought that providing an update for neurologic complications of COVID-19 would be useful for physicians and especially young trainees in neurology and neurosurgery. Indeed, in this review we discuss several neurologic aspects reported in the literature to date including the evidence and pathways of neuroinvasion in COVID-19 and the main neurologic disorders reported in the literature to date, as well as future perspectives and the potential long-term consequence of current neuroinfection in COVID-19 patients. RESULTS: Currently, there is convincing evidence that SARS-CoV-2, the etiologic agent of COVID-19, can affect the nervous system, with damage and neurologic alterations. These neurologic disorders are grouped into several categories, ranging from nonspecific and moderate symptoms such as headache, myalgia, and hyposmia to severe symptoms including cerebrovascular disease and intracranial infections. Severe neurologic symptoms such as acute cerebrovascular disease occur only in a minority of patients with usual risk factors and are associated with poor outcome. However, most COVID-19 patients exhibit only minor or mild neurologic symptoms. CONCLUSIONS: Management of COVID-19 patients should include early clinical, radiologic, and laboratory neurologic assessment, with a close follow-up, especially in severe forms. Future studies should assess late and long-term consequences of current COVID-19 patients with neurologic involvement.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 38 条
  • [1] Abdennour L, 2012, Ann Fr Anesth Reanim, V31, pe101, DOI 10.1016/j.annfar.2012.04.013
  • [2] Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature
    Algahtani, Hussein
    Subahi, Ahmad
    Shirah, Bader
    [J]. CASE REPORTS IN NEUROLOGICAL MEDICINE, 2016, 2016
  • [3] Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
    Baig, Abdul Mannan
    Khaleeq, Areeba
    Ali, Usman
    Syeda, Hira
    [J]. ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07): : 995 - 998
  • [4] Neurologic Alterations Due to Respiratory Virus Infections
    Bohmwald, Karen
    Galvez, Nicolas M. S.
    Rios, Mariana
    Kalergis, Alexis M.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
  • [5] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
    Chen, Nanshan
    Zhou, Min
    Dong, Xuan
    Qu, Jieming
    Gong, Fengyun
    Han, Yang
    Qiu, Yang
    Wang, Jingli
    Liu, Ying
    Wei, Yuan
    Xia, Jia'an
    Yu, Ting
    Zhang, Xinxin
    Zhang, Li
    [J]. LANCET, 2020, 395 (10223) : 507 - 513
  • [6] Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus
    Chen, Zhi-Min
    Fu, Jun-Fen
    Shu, Qiang
    Chen, Ying-Hu
    Hua, Chun-Zhen
    Li, Fu-Bang
    Lin, Ru
    Tang, Lan-Fang
    Wang, Tian-Lin
    Wang, Wei
    Wang, Ying-Shuo
    Xu, Wei-Ze
    Yang, Zi-Hao
    Ye, Sheng
    Yuan, Tian-Ming
    Zhang, Chen-Mei
    Zhang, Yuan-Yuan
    [J]. WORLD JOURNAL OF PEDIATRICS, 2020, 16 (03) : 240 - 246
  • [7] Toxic Encephalopathy
    Dobbs, Michael R.
    [J]. SEMINARS IN NEUROLOGY, 2011, 31 (02) : 184 - 193
  • [8] Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
    Filatov, Asia
    Sharma, Pamraj
    Hindi, Fawzi
    Espinosa, Patricio S.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [9] Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
    Gheblawi, Mahmoud
    Wang, Kaiming
    Viveiros, Anissa
    Quynh Nguyen
    Zhong, Jiu-Chang
    Turner, Anthony J.
    Raizada, Mohan K.
    Grant, Maria B.
    Oudit, Gavin Y.
    [J]. CIRCULATION RESEARCH, 2020, 126 (10) : 1456 - 1474
  • [10] Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
    Giacomelli, Andrea
    Pezzati, Laura
    Conti, Federico
    Bernacchia, Dario
    Siano, Matteo
    Oreni, Letizia
    Rusconi, Stefano
    Gervasoni, Cristina
    Ridolfo, Anna Lisa
    Rizzardini, Giuliano
    Antinori, Spinello
    Galli, Massimo
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 889 - 890